Avicularin
CAS No. 572-30-5
Avicularin( —— )
Catalog No. M18833 CAS No. 572-30-5
Avicularin exhibits anti-inflammatory activity through the suppression of ERK signaling pathway in LPS-stimulated RAW 264.7 macrophage cells.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 129 | In Stock |
|
| 10MG | 192 | In Stock |
|
| 25MG | 325 | In Stock |
|
| 50MG | 486 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameAvicularin
-
NoteResearch use only, not for human use.
-
Brief DescriptionAvicularin exhibits anti-inflammatory activity through the suppression of ERK signaling pathway in LPS-stimulated RAW 264.7 macrophage cells.
-
DescriptionAvicularin exhibits anti-inflammatory activity through the suppression of ERK signaling pathway in LPS-stimulated RAW 264.7 macrophage cells. Avicularin inhibits the accumulation of the intracellular lipids by decreasing C/EBPα-activated GLUT4-mediated glucose uptake in adipocytes and potently inhibiting fatty acid synthase.
-
In VitroCell Proliferation Assay Cell Line:Huh7 cells Concentration:25, 50, 100 μg/mL Incubation Time:12, 24, 36 and 48 h Result:Inhibited cell proliferation in a dose-dependent manner.Western Blot Analysis Cell Line:RAW 264.7 cells Concentration:10, 30, 100, 300 μM Incubation Time:1 h Result:Inhibited LPS-induced protein expression of iNOS and COX-2, release of pro-inflammatory cytokine IL-1β, degradation of cytosolic IκB, and phosphorylation of ERK.RT-PCR Cell Line:3T3-L1 cells Concentration:50 μM Incubation Time:6 days Result:Decreased PPARγ, C/EBPα, and aP2 mRNA levels approximately 28.7, 69.5, and 18.3%, respectively.
-
In VivoAnimal Model:ACLT (anterior cruciate ligament transection)-induced rats Dosage:0.5, 1, 2 mg/kg Administration:Injected into the articular cavity of the right knee, twice a week for 4 weeks.Result:Alleviated the tibial subchondral osteolysis, reduces bone loss, and increases the bone mass of tibial subchondral bone.Attenuated ECM degradation, the loss of Aggrecan and Collagen II in ACLT-induced rats. Decreased the MMP3 and MMP13 protein level. Animal Model:Rats with amyloid Beta-induced Alzheimer's disease Dosage:25, 50, and 100 mg/kg Administration:Oral administration, for 21 days Result:Enhanced cognition activity, and reversed the effects of amyloid beta-induced inflammatory response and excessive oxidative stress.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorERK
-
Research AreaOthers-Field
-
Indication——
Chemical Information
-
CAS Number572-30-5
-
Formula Weight434.35
-
Molecular FormulaC20H18O11
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (230.23 mM)
-
SMILESC1=CC(=C(C=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)OC4C(C(C(O4)CO)O)O)O)O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
m-PEG4-SH
m-PEG4-SH is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.
-
Doripenem Hydrate
Doripenem monohydrate is a new member of the carbapenem class of beta-lactam?antibiotics?with broad-spectrum coverage of Gram-positive, Gram-negative and anaerobic pathogens.
-
β-Casein (90-96)
α-Casein (90-96) is a peptide with sequence of Arg-Tyr-Leu-Gly-Tyr-Leu-Glu.
Cart
sales@molnova.com